Symptom

Memory Problems: When to Worry and What Tests Help

Occasional forgetfulness is normal. But progressive memory loss that affects daily life, especially with personality change, requires prompt evaluation to find treatable and serious causes.

Normal aging
Slower recall — not loss of function
Dementia prevalence
~1 in 14 over 65 (UK)
Treatable causes
B12, thyroid, depression, medication side effects
MCI
Mild cognitive impairment — 15% annual conversion to dementia

Normal Aging vs Dementia vs MCI

FeatureNormal AgingMCIDementia
Memory lapsesNames, words — recalled laterNoticeable; consistent; forget recent eventsSignificant impairment; repeated questions
ADLs (daily activities)IntactMostly intact; may need promptsImpaired — can't manage independently
InsightPresentPresentOften reduced
ProgressionStablePossible conversion to dementiaProgressive
LanguageNormalMild word-findingSignificant aphasia (Alzheimer's)

Reversible Causes to Rule Out First

MMSE and MoCAThe Mini-Mental State Examination (MMSE) and Montreal Cognitive Assessment (MoCA) are brief 10-minute cognitive screening tools used in primary care. MoCA is more sensitive for MCI. A score <26/30 on MoCA warrants further investigation.
What blood tests should be done for memory problems?
TSH, B12, folate, FBC, CRP, eGFR, glucose, LFTs, calcium. These rule out the most common and treatable causes. If all normal, refer to memory clinic for neuropsychological assessment and MRI brain.
How is Alzheimer's disease diagnosed?
Clinical assessment + cognitive testing + MRI brain (hippocampal atrophy) + (if needed) CSF biomarkers (amyloid β42, tau) or amyloid PET scan. Diagnosis is a clinical judgement — not a simple blood test.
What is the difference between Alzheimer's and vascular dementia?
Alzheimer's: insidious onset, gradual progression, memory loss early. Vascular: stepwise deterioration, executive dysfunction prominent, multiple small strokes or white matter changes on MRI. Many people have mixed dementia.
What helps slow dementia progression?
No drug cures dementia. Cholinesterase inhibitors (donepezil, rivastigmine) slow cognitive decline in Alzheimer's by 6–12 months. Lecanemab (anti-amyloid antibody) is now approved for early Alzheimer's in the US. Social engagement, exercise, and cognitive stimulation help.
Medical Disclaimer: This page is for general education only and does not replace professional medical advice. Always consult a qualified healthcare provider.